lactic acid has been researched along with fluorouracil in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.03) | 18.7374 |
1990's | 14 (14.43) | 18.2507 |
2000's | 33 (34.02) | 29.6817 |
2010's | 47 (48.45) | 24.3611 |
2020's | 2 (2.06) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Conway, M; Khoobehi, B; Peyman, GA; Soike, K | 1 |
Kanda, T; Kubo, T; Maruyama, Y; Sakamoto, M | 1 |
Bouffard, P; Caty, A; Fournier, C; Hecquet, B; Krikorian, A; Lefebvre, JL; Merle, S; Vanseymortier, L; Vert, M; Vilain, MO | 1 |
Honda, Y; Hyon, SH; Ikada, Y; Moritera, T; Ogura, Y; Wada, R | 1 |
Yamashita, R | 1 |
Benoit, JP; Boisdron-Celle, M; Menei, P | 1 |
Cheng, YL; Chiu, WJ; Gould, L; Heathcote, JG; Liu, GS; Menon, IA; Rootman, DS; Sheardown, H; Trope, GE | 1 |
Cockerell, CJ; Cox, SE; Cruz, PD; Freeman, RG; Lawrence, N | 1 |
Cheng, YL; Gould, L; Heathcote, JG; Liu, GS; Menon, IA; Rootman, D; Sheardown, H; Trope, G | 1 |
Hirst, LW; Roberts, MS; Tucker, IG; Wang, G | 1 |
Cockerell, CJ; Cox, SE; Cruz, C; Freemen, RG; Lawrence, N; Witheiler, DD | 1 |
Arellano, M; Malet-Martino, M; Martino, R; Spector, T | 1 |
Aboagye, EO; Bhujwalla, ZM; Glickson, JD; Shungu, DC | 1 |
Ciftci, K; Ercan, TM; Guven, O; Hincal, AA; Kas, HS; Ruacan, S; Sungur, A | 1 |
Hagiwara, A; Hyon, S; Ikada, Y; Muranishi, S; Sakakura, C; Shirasu, M; Takahashi, T; Togawa, T; Yamasaki, J | 1 |
Chang, CJ; Chiang, CH; Chou, PI; Lu, DW; Yeh, MK | 1 |
Chiang, CH; Lu, DW; Tung, SM; Yeh, MK | 1 |
Akhtar, S; Beale, G; Hughes, M; Hussain, M | 1 |
Benoit, JP; Deverre, JR; Hindré, F; Lemaire, L; Roullin, VG; Venier-Julienne, MC; Vienet, R | 1 |
Gao, J; Nasongkla, N; Qian, F | 1 |
Benoit, J; Bruna, E; Faisant, N; Haffner, J; Laffineur, V; Oury, P; Siepmann, J | 1 |
Hwang, YH; Park, SP; Suh, CK | 1 |
Jonnalagadda, S; Robinson, DH | 1 |
Ciftci, K; Gupte, A | 1 |
Chae, GS; Cho, SH; Khang, G; Kim, MS; Lee, HB; Lee, JS | 1 |
Aksungur, P; Iskit, AB; Senel, S; Squier, CA; Sungur, A; Unal, S | 1 |
Akhtar, S; Beck, G; Benboubetra, M; Benter, IF; Fox, S; Khan, A; Ng, KW; Sayyed, PZ | 1 |
Hayasaka, K; Kato, M; Shiihara, T | 1 |
Dai, H; Elmquist, WF; Hitzman, CJ; Wiedmann, TS | 1 |
Chang, J; Chen, QK; Huang, KH; Liu, JH; Liu, XY; Zhu, ZH | 1 |
Bozkir, A; Saka, OM | 1 |
Hai, BL; Jeong, YK; Khang, G; Kim, JM; Kim, YS; Seo, KS | 1 |
Akiki, J; Benoit, JP; Faisant, N; Siepmann, F; Siepmann, J | 1 |
Copoví, A; Díez-Sales, O; Herráez-Domínguez, JV; Herráez-Domínguez, M | 1 |
Domb, AJ; Ezra, A; Slivniak, R | 1 |
Gao, H; Gu, Y; Ping, Q | 1 |
Blanco, MD; Muñíz, E; Olmo, R; Sastre, RL; Teijón, C; Teijón, JM | 1 |
Huang, KH; Li, XX; Liu, JH; Lu, XP; Zhou, SY; Zhu, ZH | 1 |
Chen, QK; Chen, RF; Huang, KH; Liu, JH; Min, J; Wang, LY; Zhu, ZH | 1 |
Kim, JS; Son, HJ | 1 |
Chen, G; Li, X; Ping, Q; Wei, P; Xu, Y | 1 |
Ahn, SH; Chi, SC; Chu, WS; Ha, WS; Lee, JH; Park, CW | 1 |
Cui, LJ; Huang, J; Li, XH; Sun, NX; Yang, JG | 1 |
Deng, L; Dong, A; Liu, Y; Xing, J; Zhai, Y; Zhang, Q | 1 |
Guo, H; Huang, KH; Lan, YQ; Song, X; Xiao, JH; Zhang, C; Zhuo, YH | 1 |
Bagatin, E; Hassun, KM; Michalany, NS; Pereira, T; Talarico, S; Teixeira, SP | 1 |
Miyazaki, N; Tabata, Y | 1 |
Xu, W; Yang, Y | 1 |
Ahn, SH; Chi, SC; Danh, SD; Park, CW; Park, ES; Park, SH; Rhee, YS | 1 |
Artemov, D; Jacobs, I; Kato, Y; Onuki, Y | 1 |
Agarwal, A; Agrawal, GP; Agrawal, H; Jain, S; Mishra, AK; Mishra, P; Rai, G; Yadav, AK | 1 |
He, G; He, ZY; Hou, SX; Li, JM; Li, SZ; Luo, X; Luo, YF; Song, XR; Wei, YQ; Yang, L; Yu, S; Zheng, Y | 1 |
Berenberg, JL; Christian, D; Delaune, R; Loprinzi, CL; Menon, SP; Pajon, ER; Qin, R; Rowland, KM; Satele, DV; Thomas, S; Wolf, SL | 1 |
Hasbak, P; Jensen, SA; Mortensen, J; Sørensen, JB | 1 |
Agarwal, A; Agrawal, GP; Agrawal, H; Bid, H; Jain, S; Mishra, AK; Rai, G; Yadav, AK | 1 |
Dhanawat, M; Kumar, R; Nagarwal, RC; Pandit, JK | 1 |
Faroun, M; Husseini, GA; Karmi, A; Sowwan, M | 1 |
Jagadeeshan, S; Kumar, GS; Nair K, L; Nair, SA | 1 |
Asmatulu, R; Chen, YY; Chu, HY; Ho, JC; Misak, HE; Song, Z; Wamocha, HL; Yang, SY | 1 |
Chen, T; Gao, Y; Lu, W; Ren, X; Zheng, N | 1 |
Li, Y; Lin, Y; Ooi, CP | 1 |
Chen, D; Ding, M; Li, J; Pu, Y; Wang, S; Zhu, M | 1 |
Ham, IH; Han, SU; Hur, H; Kim, YB; Lee, G; Shim, W; Xuan, Y; Yun, J | 1 |
Lu, W; Zheng, N; Zhou, M | 1 |
Kong, L; Li, P; Wang, Y | 1 |
Arica-Yegin, B; Caliş, S; Goracinova, K; Ocal, H; Vural, I | 1 |
Chen, Y; Sun, W; Yuan, W | 1 |
Chen, Y; Hu, J; Liu, W; Wei, J | 1 |
Du, C; Lu, W; Wang, S; Zheng, N; Zhou, M | 1 |
Fu, T; Gu, J; Guo, Y; Jin, H; Lai, Y; Wang, L; Wang, X; Wang, Y; Yao, Q; Ye, X | 1 |
Agostino, G; Cutrignelli, A; Denora, N; Franco, M; Laquintana, V; Lasorsa, FM; Lopalco, A; Lopedota, A | 1 |
Cheng, Z; Dai, Z; Jin, Y; Liang, X; Ma, X; Tian, J; Yang, X | 1 |
Chen, L; Gao, W; Kong, LX; Li, P; Wang, Y; Zeng, F | 1 |
Balasubramanian, S; Girija, AR; Iwai, S; Kizhikkilot, V; Maekawa, T; Nagaoka, Y; Nair, SD; Suzuki, M; Yoshida, Y | 1 |
Dangi, R; Gulbake, A; Hurkat, P; Jain, A; Jain, SK; Shilpi, S | 1 |
Bao, R; Ding, Q; Gu, J; Li, M; Liu, Y; Shu, Y; Weng, H; Wu, W; Wu, X; Yang, J; Zhang, L | 1 |
Ghaznavi, H; Khoee, S; Khoei, S; Shakeri-Zadeh, A; Sharifi, AM; Shiran, MB | 1 |
Çakmak, AS; Gümüşderelioğlu, M; Kutlu, C | 1 |
Hajikarimi, Z; Khoee, S; Khoei, S; Mahdavi, SR | 1 |
Ashwanikumar, N; Kumar, GSV; Kumar, NA; Nair, SA | 1 |
Asha Nair, S; Ashwanikumar, N; Kumar, NA; Vinod Kumar, GS | 1 |
Chen, F; Chen, Z; Huang, Y; Li, J; Peng, J; Wang, X; Zhong, C; Zhuang, M | 1 |
Cortés, ME; de Castro Rodrigues, G; Denadai, ÂM; Gontijo, SM; Guimarães, PP; Lula, IS; Oliveira, SR; Sinisterra, RD | 1 |
Amorim, R; Baltazar, F; Miranda-Gonçalves, V; Moyer, MP; Pereira, H; Pinheiro, C; Preto, A | 1 |
Chung, FF; Hii, LW; Ho, GF; Leong, CO; Malik, RA; Ng, CH; See, MH; Soo, JS; Taib, NA; Tan, BS; Tan, SH; Teh, YC; Teo, SH; Yip, CH | 1 |
Ahmed, SH; Elmalahy, MH; Masloub, SM; Mohamed, WS; Sabry, D | 1 |
Azadbakht, M; Jahani, M; Mansouri, K; Norooznezhad, F | 1 |
Iyer, AK; Jain, S; Kashaw, SK; Sahu, P; Sau, S | 1 |
Arias, JL; Cabeza, L; Clares, B; Mallandrich, M; Melguizo, C; Prados, J; Pretel, E; Suñer, J | 1 |
Gao, Z; Li, Z; Wang, P; Yan, J | 1 |
Geary, SM; Leelakanok, N; Salem, AK | 1 |
Geary, S; Leelakanok, N; Salem, A | 1 |
Kamiki, Y; Makino, K; Takeuchi, I | 1 |
Fu, X; Mao, L; Qiu, YD; Tang, N; Xie, WQ | 1 |
Bae, J; Hee Lee, E; Kim, H; Kim, J; Kim, MS; Kwak, D; Lee, J; Phyu Hlaing, S; Ryong Moon, H; Saparbayeva, A; Yoo, JW; Yoon, IS | 1 |
1 review(s) available for lactic acid and fluorouracil
Article | Year |
---|---|
Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Fluorouracil; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |
5 trial(s) available for lactic acid and fluorouracil
Article | Year |
---|---|
Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
Topics: Adult; Animals; Antineoplastic Agents; Delayed-Action Preparations; Dogs; Dose-Response Relationship, Drug; Drug Implants; Fluorouracil; Head and Neck Neoplasms; Humans; Injections, Intravenous; Injections, Subcutaneous; Lactic Acid; Leukemia P388; Male; Mice; Middle Aged; Necrosis; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Inbred Strains; Skin; Vinblastine; Vinorelbine | 1991 |
A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
Topics: Drug Combinations; Ethanol; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Lactates; Lactic Acid; Male; Resorcinols; Salicylates; Sunlight; Trichloroacetic Acid | 1995 |
Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
Topics: Adult; Animals; Antifungal Agents; Biological Availability; Body Weight; Chitosan; Cricetinae; Cross-Over Studies; Drug Delivery Systems; Drug Therapy, Combination; Fluorouracil; Gels; Histocytochemistry; Humans; Lactic Acid; Male; Mesocricetus; Mouth Mucosa; Nystatin; Polyphosphates; Saliva; Stomatitis; Survival Rate; Treatment Outcome; Water | 2004 |
Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Double-Blind Method; Drug Combinations; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Keratolytic Agents; Lactic Acid; Male; Middle Aged; Neoplasms; Syndrome; Urea | 2010 |
Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Colorectal Neoplasms; Female; Fluorouracil; Humans; Lactic Acid; Leucovorin; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Organoplatinum Compounds; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left | 2010 |
91 other study(ies) available for lactic acid and fluorouracil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates.
Topics: Animals; Biocompatible Materials; Chlorocebus aethiops; Cytarabine; Drug Carriers; Fluorouracil; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Vitreous Body | 1992 |
[Studies on a slow releasing anticancer agent for prevention of peritoneal recurrence of advanced gastrointestinal carcinomas (clinical study)].
Topics: Delayed-Action Preparations; Duodenal Neoplasms; Fluorouracil; Humans; Infusions, Parenteral; Lactates; Lactic Acid; Peritoneal Neoplasms; Polyesters; Polymers; Rectal Neoplasms; Stomach Neoplasms | 1992 |
[Intravitreal drug delivery by microspheres of biodegradable polymers].
Topics: Animals; Biodegradation, Environmental; Delayed-Action Preparations; Drug Carriers; Fluorouracil; Lactates; Lactic Acid; Microspheres; Polyesters; Polymers; Rabbits; Vitreous Body | 1990 |
[Experimental study of an anticancer drug delivery system using polylactic acid].
Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; Fluorouracil; Infusion Pumps; Lactates; Lactic Acid; Liver Neoplasms, Experimental; Male; Needles; Polyesters; Polymers; Rats; Rats, Inbred Strains | 1987 |
Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
Topics: Biocompatible Materials; Biodegradation, Environmental; Brain Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Fluorouracil; In Vitro Techniques; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Reproducibility of Results | 1995 |
Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Conjunctiva; Drug Delivery Systems; Filtering Surgery; Fluorouracil; Glaucoma; Glycolates; Lactates; Lactic Acid; Polymers; Rabbits; Random Allocation | 1994 |
Fifty:fifty poly (DL glycolic acid-lactic acid) copolymer as a drug delivery system for 5-fluorouracil: a histopathological evaluation.
Topics: Animals; Biocompatible Materials; Conjunctiva; Drug Delivery Systems; Fibrosis; Fluorouracil; Glycolates; Granuloma, Foreign-Body; Guinea Pigs; Lactates; Lactic Acid; Polymers; Rabbits; Sclera | 1994 |
In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
Topics: Animals; Biocompatible Materials; Conjunctiva; Delayed-Action Preparations; Drug Implants; Fluorouracil; Glaucoma; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostheses and Implants; Rabbits; Sclera; Tissue Distribution | 1996 |
Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
Topics: Administration, Topical; Chemexfoliation; Drug Combinations; Ethanol; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Lactic Acid; Male; Resorcinols; Salicylates; Sunlight; Trichloroacetic Acid | 1997 |
5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model.
Topics: Animals; Bile; Enzyme Inhibitors; Fluoroacetates; Fluorouracil; In Vitro Techniques; Lactic Acid; Liver; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Uracil | 1997 |
Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Fibrosarcoma; Fluorouracil; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiography; Treatment Outcome | 1998 |
Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
Topics: Animals; Antimetabolites, Antineoplastic; Biodegradation, Environmental; Chemistry, Pharmaceutical; Drug Delivery Systems; Female; Fluorouracil; Humans; Lactic Acid; Liver Neoplasms, Experimental; Microspheres; Molecular Weight; Particle Size; Polyesters; Polymers; Rats; Rats, Wistar; Technetium; Tissue Distribution; Viscosity | 1997 |
Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice.
Topics: Animals; Biocompatible Materials; Colonic Neoplasms; Fluorouracil; Injections, Intraperitoneal; Lactic Acid; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Microspheres; Peritoneal Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solutions | 1998 |
Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits.
Topics: Animals; Antimetabolites; Biocompatible Materials; Conjunctiva; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Therapy, Combination; Emulsions; Female; Fluorouracil; Intraocular Pressure; Lactic Acid; Male; Microspheres; Mitomycin; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prospective Studies; Rabbits; Random Allocation; Trabeculectomy; Wound Healing | 2000 |
In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres.
Topics: Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Drug Carriers; Drug Implants; Female; Filtering Surgery; Fluorouracil; In Vitro Techniques; Lactic Acid; Male; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Sclera | 2001 |
Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Interactions; Electrophoresis; Fluorouracil; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Oligonucleotides, Antisense; Particle Size; Phosphorus Radioisotopes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2002 |
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Brain; Brain Neoplasms; Contrast Media; Diffusion; Drug Carriers; Female; Ferrosoferric Oxide; Fluorouracil; Glioma; Injections; Iron; Lactic Acid; Microspheres; Neoplasm Transplantation; Oxides; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Tritium | 2002 |
Membrane-encased polymer millirods for sustained release of 5-fluorouracil.
Topics: Antineoplastic Agents; Delayed-Action Preparations; Fluorouracil; Kinetics; Lactic Acid; Membranes, Artificial; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sodium Chloride; Time Factors | 2002 |
The effect of gamma-irradiation on drug release from bioerodible microparticles: a quantitative treatment.
Topics: Antimetabolites, Antineoplastic; Diffusion; Excipients; Fluorouracil; Gamma Rays; Kinetics; Lactic Acid; Microspheres; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2002 |
Multifocal inflammatory leukoencephalopathy: use of thallium-201 SPECT and proton MRS.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Aspartic Acid; Axons; Biopsy; Brain; Brain Neoplasms; Choline; Colorectal Neoplasms; Diagnosis, Differential; Fluorouracil; Humans; Lactic Acid; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Metastasis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2003 |
A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery.
Topics: Calorimetry, Differential Scanning; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Fluorouracil; Hot Temperature; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Membranes, Artificial; Models, Chemical; Osmotic Pressure; Polyesters; Polyethylene Glycols; Polymers | 2000 |
Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres.
Topics: Antineoplastic Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Combinations; Female; Fluorouracil; Humans; Lactic Acid; Microspheres; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tumor Cells, Cultured | 2004 |
Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Topics: Contraceptive Agents; Diffusion; Drug Carriers; Fluorouracil; Hydrogen-Ion Concentration; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Water | 2004 |
Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
Topics: Animals; Autoradiography; DNA, Catalytic; Drug Delivery Systems; Fluorouracil; Gene Silencing; In Vitro Techniques; Kidney; Lactic Acid; Liver; Mice; Mice, Inbred BALB C; Microspheres; Oligonucleotides, Antisense; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; RNA, Catalytic; RNA, Small Interfering; Spleen; Time Factors | 2004 |
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.
Topics: Adolescent; Brain Diseases, Metabolic; Corpus Callosum; Diagnosis, Differential; DNA, Mitochondrial; Female; Fluorouracil; Humans; Immunosuppressive Agents; Interleukin-6; Lactic Acid; Magnetic Resonance Imaging; Mitochondrial Diseases; Mitochondrial Proton-Translocating ATPases; Mutation | 2005 |
Measurement of drug release from microcarriers by microdialysis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Algorithms; Calibration; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Fluorouracil; Kinetics; Lactic Acid; Liposomes; Microdialysis; Microsomes; Particle Size; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results | 2005 |
[Preparation and release efficiency of polylactic acid nanoparticle].
Topics: Antimetabolites, Antineoplastic; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Fluorouracil; Lactic Acid; Nanoparticles; Particle Size; Polyesters; Polymers | 2005 |
Formulation and investigation of 5-FU nanoparticles with factorial design-based studies.
Topics: Anti-Infective Agents; Antimetabolites, Antineoplastic; Drug Delivery Systems; Drug Design; Fluorouracil; Glycolates; Kinetics; Lactic Acid; Models, Chemical; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility | 2005 |
Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
Topics: Dexamethasone; Drug Delivery Systems; Fluorouracil; Glycolates; Hydrogen-Ion Concentration; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Molecular Structure; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Time Factors; Water | 2005 |
Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
Topics: Antimetabolites, Antineoplastic; Buffers; Delayed-Action Preparations; Diffusion; Drug Carriers; Fluorouracil; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Microspheres; Models, Chemical; Osmolar Concentration; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Technology, Pharmaceutical; Temperature | 2006 |
Enhancing effect of alpha-hydroxyacids on "in vitro" permeation across the human skin of compounds with different lipophilicity.
Topics: Adult; Alcohols; Butanols; Epidermis; Female; Fluorouracil; Glycolates; Humans; Hydroxy Acids; In Vitro Techniques; Lactic Acid; Pentanols; Permeability; Phenylethyl Alcohol; Skin; Skin Absorption; Sodium Dodecyl Sulfate | 2006 |
Hydrolytic degradation and drug release of ricinoleic acid-lactic acid copolyesters.
Topics: Antimetabolites, Antineoplastic; Drug Carriers; Fluorouracil; Glucocorticoids; Hydrolysis; Kinetics; Lactic Acid; Molecular Weight; Polyesters; Ricinoleic Acids; Solubility; Transition Temperature; Triamcinolone | 2006 |
The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Implants; Fluorouracil; Humans; Lactic Acid; Microspheres; Polyesters; Polymers; Technology, Pharmaceutical | 2007 |
5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Topics: Animals; Drug Delivery Systems; Fluorouracil; Injections, Subcutaneous; Lactic Acid; Macrophages; Male; Microspheres; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Technology, Pharmaceutical | 2007 |
[Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorouracil; Humans; Lactic Acid; Male; Mice; Mice, SCID; Nanoparticles; Polyesters; Polymers; Radioimmunotherapy; Stomach Neoplasms; Technetium; Vascular Endothelial Growth Factor A | 2007 |
[Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles].
Topics: Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Carriers; Fluorouracil; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Polyesters; Polymers; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Therapeutic efficacy of DNA-loaded PLGA microspheres in tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; DNA; Drug Carriers; Fluorouracil; Gene Transfer Techniques; Genetic Therapy; Interleukin-12; Lactic Acid; Mice; Mice, Inbred BALB C; Microspheres; Neoplasm Transplantation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Treatment Outcome | 2007 |
PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Biological Availability; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Emulsions; Fluorouracil; Half-Life; Lactic Acid; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical | 2008 |
Preparation of micro-fabricated biodegradable polymeric structures using NCDS.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Drug Carriers; Drug Delivery Systems; Durapatite; Elasticity; Fluorouracil; Hardness; Lactic Acid; Microscopy, Electron, Scanning; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2008 |
Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
Topics: Animals; Antimetabolites; Aqueous Humor; Chromatography, High Pressure Liquid; Conjunctiva; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Fluorouracil; Glaucoma Drainage Implants; Indicators and Reagents; Intraocular Pressure; Lactic Acid; Microspheres; Ophthalmologic Surgical Procedures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Implantation; Rabbits; Spectrophotometry, Ultraviolet; Survival Analysis | 2008 |
A new injectable thermogelling material: methoxy poly(ethylene glycol)-poly(sebacic acid-D,L-lactic acid)-methoxy poly(ethylene glycol) triblock co-polymer.
Topics: Animals; Decanoic Acids; Dicarboxylic Acids; Drug Carriers; Fluorouracil; Gels; Injections; Lactic Acid; Phase Transition; Polyethylene Glycols; Rats; Temperature | 2009 |
[The inhibitive effects of 5-fluorouracil-loaded polylactic acid nanoparticles on human Tenon's capsule fibroblast in vitro].
Topics: Cell Proliferation; Cells, Cultured; Eye; Fascia; Fibroblasts; Fluorouracil; Humans; Lactic Acid; Nanoparticles; Polyesters; Polymers | 2009 |
5-Fluorouracil superficial peel for multiple actinic keratoses.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Chemexfoliation; Drug Combinations; Drug Therapy, Combination; Ethanol; Female; Fluorouracil; Glycolates; Humans; Keratolytic Agents; Keratosis, Actinic; Lactic Acid; Male; Middle Aged; Resorcinols; Retrospective Studies; Salicylates; Treatment Outcome | 2009 |
Anti-tumor activity of carmofur water-solubilized by lactic acid oligomer-grafted pullulan nanogels.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Fluorouracil; Glucans; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Mice; Nanostructures; Solubility | 2009 |
Relationship between drug release and some physical parameters of drug sorption onto PLA fibers.
Topics: Diclofenac; Diffusion; Fluorouracil; Lactic Acid; Metformin; Models, Chemical; Pharmaceutical Preparations; Polyesters; Polymers; Solvents; Temperature; Thermodynamics | 2010 |
In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Topics: Absorbable Implants; Animals; Antimetabolites, Antineoplastic; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Durapatite; Fluorouracil; Foreign-Body Reaction; Inflammation; Kinetics; Lactic Acid; Male; Materials Testing; Nanocomposites; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rats; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical; Tissue Scaffolds | 2010 |
Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique.
Topics: Animals; Cell Line, Tumor; Contrast Media; Ferric Compounds; Fluorouracil; Humans; Lactic Acid; Magnetic Resonance Imaging; Mice; Mice, SCID; Microspheres; Nanoparticles; Nanospheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Topics: Animals; Biocompatible Materials; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Fluorouracil; Hyaluronic Acid; Lactic Acid; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Toxicity Tests; X-Ray Diffraction | 2010 |
Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Fluorouracil; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tetrazolium Salts; Thiazoles; Verapamil; Vincristine | 2010 |
Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Chondroitin Sulfates; Drug Carriers; Female; Fluorouracil; Humans; Lactic Acid; Molecular Structure; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; X-Ray Diffraction | 2010 |
Modified PLA nano in situ gel: a potential ophthalmic drug delivery system.
Topics: Animals; Aqueous Humor; Drug Delivery Systems; Female; Fluorouracil; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanoparticles; Polyesters; Polymers; Rabbits; Spectroscopy, Fourier Transform Infrared | 2011 |
Multifunctional nanovehicles for combined 5-fluorouracil and gold nanoparticles based on the nanoprecipitation method.
Topics: Chemical Precipitation; Drug Delivery Systems; Fluorouracil; Gold; Lactic Acid; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity | 2011 |
Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Topics: Acridine Orange; Antineoplastic Agents; Apoptosis; Calorimetry, Differential Scanning; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Carriers; Ethidium; Flow Cytometry; Fluorouracil; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2011 |
Cytotoxicity of release products from magnetic nanocomposites in targeted drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Drug Delivery Systems; Fluorouracil; Lactic Acid; Macrophages; Magnetite Nanoparticles; Materials Testing; Mice; Nanocomposites; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2013 |
Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.
Topics: Absorbable Implants; Animals; Drug Delivery Systems; Fluorouracil; Lactic Acid; Male; Mice; Mice, Inbred ICR; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Sarcoma, Experimental; Xenograft Model Antitumor Assays | 2012 |
5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
Topics: Antimetabolites, Antineoplastic; Durapatite; Fluorouracil; Lactic Acid; Microscopy, Electron, Scanning; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Viscosity | 2012 |
Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.
Topics: Animals; Delayed-Action Preparations; Female; Fluorouracil; HCT116 Cells; Humans; Immunohistochemistry; Lactic Acid; Mice; Mice, Inbred BALB C; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vascular Endothelial Growth Factor A | 2013 |
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Signet Ring Cell; Cell Survival; Dichloroacetic Acid; Female; Fluorouracil; Glucose; Glucose Transporter Type 1; Glycolysis; Hexokinase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Lactic Acid; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Stomach Neoplasms; Survival Rate; Tissue Array Analysis; Tumor Cells, Cultured | 2013 |
In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Chromatography, High Pressure Liquid; Drug Delivery Systems; Fluorouracil; Injections, Intraperitoneal; Lactic Acid; Male; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Distribution | 2013 |
Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
Topics: Antimetabolites, Antineoplastic; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Fluorouracil; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Nanoparticles; Nanotechnology; Photoelectron Spectroscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2013 |
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Topics: Antimetabolites, Antineoplastic; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Fluorouracil; Humans; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Propylene Glycols | 2014 |
Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Delayed-Action Preparations; Fluorouracil; Gelatin Sponge, Absorbable; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Rats; Rats, Sprague-Dawley; Survival Analysis; Xenograft Model Antitumor Assays | 2013 |
Preparation and characterization of electrospun PLGA/gelatin nanofibers as a drug delivery system by emulsion electrospinning.
Topics: Animals; Biocompatible Materials; Cells, Cultured; Cephradine; Drug Delivery Systems; Emulsions; Fluorouracil; Gelatin; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Mice; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2013 |
5-Fluorouracil delivery from a novel three-dimensional micro-device: in vitro and in vivo evaluation.
Topics: Animals; Antimetabolites, Antineoplastic; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Fluorouracil; Lactic Acid; Male; Mice; Mice, Inbred ICR; Micro-Electrical-Mechanical Systems; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Xenograft Model Antitumor Assays | 2013 |
Protective effect of curcumin on chemotherapy-induced intestinal dysfunction.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Biomarkers; Caspase 3; Curcumin; Cytoprotection; D-Amino-Acid Oxidase; Endotoxins; Fluorouracil; Ileum; Intestinal Mucosa; Lactic Acid; Protective Agents; Rats; Rats, Wistar; Time Factors; Weight Loss | 2013 |
Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Calorimetry, Differential Scanning; Carrier Proteins; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Fluorouracil; Glioma; Humans; Lactic Acid; Microscopy, Fluorescence; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, GABA-A; Tissue Distribution; Tumor Cells, Cultured | 2014 |
SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diagnostic Imaging; Drug Delivery Systems; Female; Fluorouracil; Humans; Image Processing, Computer-Assisted; Lactic Acid; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyesters; Polymers; Subcutaneous Tissue; Tumor Burden | 2014 |
Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biological Transport; Cell Survival; Colonic Neoplasms; Cross-Linking Reagents; Diamines; Drug Carriers; Drug Compounding; Drug Delivery Systems; Fluorouracil; Folic Acid; HT29 Cells; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; Microscopy, Fluorescence; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2015 |
Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Combined Modality Therapy; Curcumin; Drug Carriers; Fluorouracil; Folic Acid; Humans; Hyperthermia, Induced; Lactic Acid; Magnetite Nanoparticles; MCF-7 Cells; Mice; Nanoconjugates; Nanomedicine; Nanotechnology; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transferrin | 2014 |
Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Delivery Systems; Fluorouracil; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
[Anti-tumor effect of 5-FU-PLLA-CNTs on human gastric carcinoma cell lines in vitro].
Topics: Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Fluorouracil; Humans; Lactic Acid; Nanotubes, Carbon; Polyesters; Polymers; Stomach Neoplasms | 2014 |
A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Topics: Allografts; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Fluorouracil; Lactic Acid; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Materials Testing; Mice; Mice, Inbred BALB C; Nanocapsules; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2014 |
Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study.
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Fluorouracil; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Chemoradiotherapy; Coated Materials, Biocompatible; Dextrans; Fluorouracil; Humans; Lactic Acid; Magnetite Nanoparticles; Male; Nanocapsules; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Treatment Outcome | 2014 |
Dual drug delivery of 5-fluorouracil (5-FU) and methotrexate (MTX) through random copolymeric nanomicelles of PLGA and polyethylenimine demonstrating enhanced cell uptake and cytotoxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calorimetry, Differential Scanning; Drug Carriers; Drug Screening Assays, Antitumor; Fluorouracil; HCT116 Cells; Humans; Lactic Acid; Methotrexate; Micelles; Microscopy, Electron, Transmission; Nanostructures; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2014 |
5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles.
Topics: Calorimetry, Differential Scanning; Cell Death; Chemistry, Pharmaceutical; Drug Delivery Systems; Fluorouracil; HCT116 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Lactic Acid; Lipids; Nanoparticles; Palmitic Acid; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2014 |
Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Flavanones; Fluorouracil; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; PTEN Phosphohydrolase; Signal Transduction; Stomach Neoplasms | 2015 |
Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.
Topics: Calorimetry, Differential Scanning; Carbon-13 Magnetic Resonance Spectroscopy; Cell Death; Cell Line, Tumor; Cell Survival; Fluorouracil; Humans; Kinetics; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Static Electricity; Sulfadiazine | 2015 |
Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Glycolysis; Humans; Lactic Acid; Membrane Transport Modulators; Monocarboxylic Acid Transporters; Muscle Proteins; RNA Interference; Symporters; Time Factors; Transfection | 2015 |
Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cyclophosphamide; DNA Damage; DNA Repair; Drug Combinations; Drug Synergism; Embryonic Stem Cells; Epirubicin; Female; Fibroblasts; Fluorouracil; Glucose; Humans; Hypoglycemic Agents; Lactic Acid; Lung; Metformin; Neoplastic Stem Cells; Pyrones; Ribonucleotides; Thiophenes | 2015 |
Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fluorouracil; Head and Neck Neoplasms; Humans; Lactic Acid; Laryngeal Neoplasms; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Squamous Cell Carcinoma of Head and Neck | 2016 |
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Movement; Cell Survival; Chemokine CXCL12; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Humans; Lactic Acid; MCF-7 Cells; Models, Biological; Neoplasm Invasiveness; Nitric Oxide; Receptors, CXCR4; RNA, Messenger | 2017 |
Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Liberation; Eucalyptus; Fluorouracil; Gels; Hemolysis; Humans; Hydrogen-Ion Concentration; Lactic Acid; Nanostructures; Plant Oils; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Skin Absorption; Swine | 2017 |
Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters.
Topics: Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Fluorouracil; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Fluorouracil; Humans; Hyaluronic Acid; Irinotecan; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach Neoplasms | 2017 |
Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Implants; Female; Fluorouracil; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thymoma | 2018 |
Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy.
Topics: Alanine; Animals; Anti-Ulcer Agents; Chitosan; Coated Materials, Biocompatible; Drug Liberation; Fluorouracil; Lactic Acid; Male; Mice, Inbred ICR; Microscopy, Electron, Scanning; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinolones; Stomatitis; Treatment Outcome | 2018 |
MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glucose; Glycolysis; Humans; Irinotecan; Lactic Acid; Leucovorin; Male; Mice, Nude; Mucin-1; Neoplasm Transplantation; Oxaliplatin; Pancreatic Neoplasms | 2020 |
5-Fluorouracil crystal-incorporated, pH-responsive, and release-modulating PLGA/Eudragit FS hybrid microparticles for local colorectal cancer-targeted chemotherapy.
Topics: Animals; Colorectal Neoplasms; Drug Carriers; Drug Delivery Systems; Fluorouracil; Hydrogen-Ion Concentration; Lactic Acid; Mice; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |